Exporting Paracetamol APIs Allowed

Exporting Paracetamol APIs Allowed
NPPA Allows Six Manufacturers To Export 2000 MT

Based on DoPs’ assessment of the availability of paracetamol APIs and KSMs, permissions have been granted to Bharat Chemicals, Granules India, Para Products, Sri Krishna Pharmaceutical, Meghmani LLP, and Farmson Pharmaceuticals.

To export 2000 metric tonnes of paracetamol API, six major manufacturers of paracetamol active pharmaceutical ingredients (APIs) have been granted access by the National Pharmaceutical Pricing Authority (NPPA).

Paracetamol API can be exported by Farmson Pharmaceutical -456 MT; Meghmani LLP- 209 MT; Sri Krishna Pharmaceuticals – 474 MT; Granules India- 655 MT; Bharat Chemicals- 91 MT; Para Products- 115 MT

The President of the Indian Drugs Manufacturers Association (IDMA), Mahesh Doshi said, “By allowing the large manufacturers of paracetamol to begin the export, the government has initiated a progressive step. Companies would be allowed to fulfill the export commitments as the activities of paracetamol and hydroxychloroquine (HCQ) are monitored by the Ministry of External Affairs in a licensed category, continuously monitoring their demand position based on the stock position. The smooth functioning of pharma exports is indicated by this step. In the coming days, we look forward to other merchant exporters getting permissions as well.”

Federation of Pharma Entrepreneurs (FOPE) Chairman, B R Sikri said, “FOPE appreciates government increasing the export quantity of paracetamol in this move. Now the quantity is 2000 metric tonnes, the quantity earlier was almost 50% of the current allocation. This shows the seriousness of the government in monitoring the demand-supply scenario, as well as the stock, production, and materials in the pipeline. This is needed at the moment. To ensure that there is nobody suffering for the want of API or finished dosages, there will be more such positive decisions in days to come through this efficient way of working by the government.”

However, NPPA’s move has been questioned by an industry insider, stating that “the parameters considered must have some disclosure. On which basis this quota is given must be clarified by the respective authorities. This move initiated by the government seems to be biased. There should have been either a blanket ban or equal quantity permission to all, or a blanket approval for everyone. This initiative must be reconsidered by the authorities.”

The NPPA has requested the DCGI to continuously monitor the availability of stock of paracetamol in the domestic market and to make sure that manufacturers continue to supply the quantity of paracetamol APIs as usual to the domestic market.


Exporting Paracetamol APIs Allowed

Upload your CV to Rasayanika Talent Pool


Please enter your comment!
Please enter your name here